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The cellular prion protein PrPC consists of two
domains—aflexibleN-terminal domain,which partic-
ipates in copper and zinc regulation, and a largely
helical C-terminal domain that converts to b sheet
in the course of prion disease. These two domains
are thought to be fully independent and noninter-
acting. Compelling cellular and biophysical studies,
however, suggest a higher order structure that is
relevant to both PrPC function and misfolding in
disease. Here, we identify a Zn2+-driven N-terminal
to C-terminal tertiary interaction in PrPC. The
C-terminal surface participating in this interaction
carries the majority of the point mutations that
confer familial prion disease. Investigation of mutant
PrPs finds a systematic relationship between the
type of mutation and the apparent strength of this
domain structure. The structural features identified
here suggest mechanisms by which physiologic
metal ions trigger PrPC trafficking and control prion
disease.
INTRODUCTION
The transmissible spongiform encephalopathies (TSEs), or prion
diseases, arise frommisfolding of the cellular prion protein (PrPC)
to its bsheet-rich scrapie form (PrPSc) (Prusiner, 1998, 2003).
Among the TSEs are mad cow disease and, in humans, Creutz-
feldt-Jakob disease (CJD) (Prusiner, 1997). Mature human PrPC
is a 209-amino acid, membrane-anchored glycoprotein pos-
sessing two domains: a flexible N-terminal segment (up to
residue 124) (Donne et al., 1997) that selectively binds copper
and zinc, and a predominantly helical C-terminal domain. Metal
ion regulation is one of several functions ascribed to PrPC in its
role in neuron development and maintenance (Aguzzi et al.,
2008; Millhauser, 2007).
The prion protein’s two domains are often thought to be nonin-
teracting—a structured C terminus with an N-terminal tail. This
scheme cannot be correct in light of current cellular and biophys-
ical observations. For example, studies with monoclonal anti-
bodies (mAbs), aimed at identifying reactive surface sites that236 Structure 21, 236–246, February 5, 2013 ª2013 Elsevier Ltd All rcatalyze the PrPC to PrPSc conversion, find that mAbs with
N-terminal epitopes block C-terminal mAbs access and result
in partial C-terminal unfolding (Li et al., 2009). In addition, fibro-
blasts expressing mouse PrPC with the C-terminal E199K muta-
tion (E200K in human), which causes familial CJD, when
compared to wild-type exhibit reduced N-terminal copper
uptake and are more susceptible to copper toxicity (Canello
et al., 2012). Two separate studies show that elimination of
a linker segment between the N- and C-terminal domains in
transgenic mice results in an embryonic lethal phenotype
(Baumann et al., 2007; Li et al., 2007). The developmental
derangements in these experimentswere interpreted as a conse-
quence of altered PrPC binding to an unidentified partner protein;
however, it is also possible that elimination of the linker disrupts
higher order PrPC structure. In structural investigations, nuclear
magnetic resonance (NMR) shows that the N-terminal domain
increases helix order in the C-terminal domain (Zahn et al.,
2000). EXAFS work finds that a distal mutation Q212P alters
copper coordination geometry at an N-terminal site localized
to His111 (D’Angelo et al., 2012). Finally, the addition of copper
drives the association between the N-terminal domain and helix
2 of the C terminus, possibly leading to a compact structure that
facilitates PrPSc formation (Thakur et al., 2011).
ThePrPCN-terminal domain binds both copper and zinc in vivo
and participates in metal ion homeostasis (Brown et al., 1997).
Cu2+ and Zn2+ induce PrP endocytosis (Pauly and Harris, 1998;
Perera and Hooper, 2001), upregulate PrP expression (Belling-
ham et al., 2009; Varela-Nallar et al., 2006), inhibit in vitro fibril
formation (Bocharova et al., 2005), andsuppressPrPScamplifica-
tion (Orem et al., 2006). Mutations in the copper transport protein
Atp7a, leading to reduced brain copper content, slow prion
disease progression after PrPSc inoculation (Siggs et al., 2012).
Moreover, copper, zinc, and iron distribution in the mouse brain
depends on PrP expression levels (Pushie et al., 2011). PrP is
evolutionarily linked to the ZIP metal ion transport family, further
supporting its role as a metal-binding protein (Schmitt-Ulms
et al., 2009). The ways in which Cu2+ and Zn2+ coordinate to
N-terminal PrP are distinct. Cu2+ interacts with the octarepeat
domain, residues 60–91 with the sequence (PHGGGWGQ)4
(Burns et al., 2002, 2003), and also segments at His96 and
His111 (human sequence; Figure 1A) (Walter et al., 2009). The
specific coordination features depend on the Cu2+-to-protein
ratio (Chattopadhyay et al., 2005; Millhauser, 2007). In contrast,
Zn2+ binding is restricted to the octarepeat domain, in which all
four histidines coordinate a single Zn2+ ion (Walter et al., 2007),ights reserved
Figure 1. Sequence and Structure of
Human PrPC
(A) Schematic diagram of PrP (human sequence)
with numbering indicating secondary structure,
posttranslational modifications, and pathogenic/
protective mutations. The N terminus, which
contains the octarepeat domain, is unstructured in
the absence of Zn2+. The structured C-terminal
domain possesses two N-linked carbohydrates
(ovals), a disulfide bond, and a GPI anchor. The
inherited pathogenic mutations that involve amino
acid substitutions resulting in a change of charge
are indicated in red. The protective polymorphism
is in blue.
(B) Zn2+ binds to the histidines within the octar-
epeat domain, as shown in the preliminary three-
dimensional model.
Structure
Zinc-Driven Tertiary Interaction in PrPCasshown inFigure 1B.Thedissociation constant of this coordina-
tion mode is approximately 200 mM (Walter et al., 2007).
A very recent study shows that PrPC facilitates zinc uptake into
neuronal cells mediated by a-amino-3-hydroxy-5-methyl-4-iso-
xazolepropionate (AMPA) receptors (Watt et al., 2012). Zinc
transport by this mechanism is independent of PrPC endocy-
tosis, but does require the PrP octarepeat domain. Moreover,
disease-associated PrP mutants, or misfolding to PrPSc, inhibit
this metal ion transport mechanism. These findings may explain
why zinc is reduced in the hippocampus and other brain regions
in prion disease.
Here, we use magnetic resonance to evaluate how metal ions
affect the structure of full-length mouse PrP [MoPrP(23–230)].
We use Zn2+ because it is a natural coordinating species that
stimulates well-characterized, PrP-linked physiologic processes
(Brown et al., 1997; Pauly and Harris, 1998; Perera and Hooper,
2001;Watt et al., 2012).Moreover, Zn2+ is diamagnetic, thus facil-
itating the interpretation of the nuclear magnetic resonance
(NMR) spectra.Using1H-15NHSQCNMR,wefind thatZn2+drives
a tertiary contact between the octarepeat domain and a specific
surface on the C-terminal domain. These findings are supported
by direct distancemeasurements using double electron-electron
resonance (DEER) EPR. Analysis of the cumulative data shows
that the relevant C-terminal surface participating in this interac-
tion carries the majority of PrP mutations that give rise to familial
prion disease. We then examine several disease-associated PrP
mutants, as well as a dominant negative polymorphism, and find
a systematic relationship between the type of mutation and the
NMR features of the Zn2+-driven interdomain interaction. Consid-
eration of this relationship suggests that electrostatics play an
important role in stabilizing the global PrP-Zn2+ structure, and
this finding is supported by direct surface potential calculations.
This work identifies a higher order structure in PrPC, and provides
insight into the protein’s function as well as conversion to PrPSc.Structure 21, 236–246, February 5, 2013RESULTS
Zinc Drives an N-Terminal to
C-Terminal Interaction in MoPrPC
To test whether the N and C termini of
MoPrP physically interact upon Zn2+
binding, we titrated the metal ion intofull-length murine prion protein, MoPrP(23–230), (50 mM) at
pH 7.4 in 50 mM MOPS buffer and acquired 1H-15N HSQC
spectra (Figure 2; Figure S1 available online). Spectra of the
C-terminal structured region were assigned using the data
deposited for MoPrP(90–231) at pH 7.0 (Biological Magnetic
Resonance Bank ID: 16071). HSQC cross peaks derived from
PrP-Zn2+ relative to protein alone were assigned to one of three
categories: no change, change in chemical shift, or complete
disappearance (Table S1). The addition of three equivalents of
zinc resulted in disappearance of 21 of the 101 assigned back-
bone amides in the C-terminal domain, and significant shifts of
five cross peaks. Loss of these cross peaks is consistent with
a chemical environment in intermediate exchange. Residues
affected by the addition of Zn2+ are mapped onto the secondary
structure in Figure 3A. We observed three primary regions of
interaction: the short loop just before helix 1, the solvent exposed
surface of helix 2, and the N-terminal, exposed surface of helix 3.
Amino acids marking the boundaries of these regions are indi-
cated. Figure 3B, a surface plot, shows that these residues
form two proximal and nearly contiguous patches located
primarily on helices 2 and 3.
The observed influence of added Zn2+ can arise from either its
direct interaction with the C-terminal domain, or by binding
first to the N-terminal octarepeat domain, which then associates
with the C-terminal domain. To distinguish between these
two possibilities, we repeated HSQC titration experiments with
MoPrP(91–230), lacking most of the N-terminal region including
the octarepeat domain, and the result is shown in Figure 3C. In
contrast to full-length PrPC, only three resonances disappeared,
while all others remained unaffected. Consequently, the octare-
peat domain is required for the observed influence of Zn2+ on the
HSQC cross peaks in the C-terminal domain. Specifically, Zn2+
itself does not significantly perturb the C-terminal resonances
but, instead, coordinates to the octarepeat histidines, partiallyª2013 Elsevier Ltd All rights reserved 237
Figure 2. Selected Region of the 1H-15N HSQCNMRSpectra ofWild-
type MoPrP
The black spectrum is from the protein in the absence of Zn2+. The red
spectrum is from addition of three equivalents of ZnCl2 and shows chemical
shift changes, and loss or broadening of select cross peaks.
See also Figure S1.
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Zinc-Driven Tertiary Interaction in PrPCordering this domain, which then folds onto the C-terminal
domain forming a tertiary contact with the exposed surfaces of
helices 2 and 3. Moreover, because MoPrP(91–230) contains
histidines 95 and 110, we conclude that the imidazoles from
these residues are not sufficient for driving the observed
N-terminal to C-terminal interaction found in full-length PrPC. In
full-length PrPC, the lack of enhanced chemical shift dispersion
from the addition of Zn2+ for residues in the octarepeat domain
suggests that the peptide segments between the coordinating
His residues do not take on a specific structure even when
docked to the PrP C-terminal domain.
To explore the strength of the N-terminal to C-terminal interac-
tion, the two domains were added in trans, along with Zn2+.
Specifically, samples were prepared with 15N MoPrP(91–230),
and increasing concentrations of PrP(23–28, 56–90) (50–500 mM)
and Zn2+ (150 mM to 2.0 mM). HSQC experiments failed to iden-
tify significantly shifted or broadened peaks in the C-terminal
domain. We conclude, therefore, that the linker region between
the N and C termini of MoPrP is essential for limiting PrP’s
conformational freedom, thereby facilitating the metal-driven
interdomain interaction.
DEER EPR Demonstrates a Zn2+-Dependent
Conformational Change
Although the HSQC experiments clearly demonstrate an interac-
tion between PrP’s two domains, they do not provide detail on
whether this ordered state is in equilibriumwith extended confor-
mations. To directly assess the conformational distribution
between the N-terminal and C-terminal domains, we measured
select interdomain distances using four-pulse double electron-
electron resonance EPR spectroscopy. The DEER technique,
in combination with nitroxide site-directed spin labeling
(SDSL), is capable of accurately measuring macromolecular
distances in the range of 20–80A˚ and has been successfully
applied in the determination of ligand-induced conformational
changes in proteins (Jeschke and Polyhach, 2007; Smirnova
et al., 2007).238 Structure 21, 236–246, February 5, 2013 ª2013 Elsevier Ltd All rDoubly spin-labeled MoPrP constructs were generated using
two different site-directed spin-labeling techniques. In the
N-terminal domain, we used the traditional method of incorpo-
rating a Cys at the desired label position, followed by reaction
with the MTSSL reagent to give the R1 spin label side chain.
Labeling in the C-terminal domain is more challenging given
the essential disulfide bond between helices 2 and 3. To avoid
non-native disulfides that might arise from a third Cys residue,
we used genetic methods to incorporate the unnatural amino
acid p-acetyl phenylalanine, followed by reaction with a hydrox-
ylamine nitroxide reagent, to produce the ketoxime-linked K1
side chain (Fleissner et al., 2009). Detailed reactions are given
in Figure S2. To test whether DEERwith the K1 label would report
meaningful distances, we produced three doubly K1 labeled PrP
constructs with both labels in the structured C-terminal domain.
As shown in Figure S2, DEER measurements agreed with the
expected distances to within 5 A˚.
We developed three R1/K1 doubly labeled PrPC constructs,
and performed DEER measurements with and without Zn2+
(Figure 4). The first contained the R1 side chain at position 66,
within the octarepeat domain, and K1 at position 200, which is
a surface site in the N-terminal region of helix 3. The HSQC
experiments suggest a Zn2+ driven interaction between these
two regions (Figure 3). In the absence of Zn2+, the dipolar
evolution for PrP(Q66R1/T200K1) is shallow and the resulting
distance distribution between the two labels is broad, consistent
with an ensemble of distances between 20 and 60 A˚, as
shown in Figure 4. However, upon addition of excess Zn2+, the
dipolar evolution deepens and the distance distribution sharpens
with a pronounced peak at approximately 22 A˚. Along with the
NMR experiments, these data demonstrate a close contact
between the Zn2+ occupied octarepeat domain and the
N-terminal segment of helix 3.
The next construct, PrP(S102R1/T200K1), has the R1 label in
the30 amino acid linker region between the octarepeat domain
and the folded C terminus. Addition of Zn2+ also sharpens the
distance distribution, with a peak at 28 A˚, but less so than
observed for PrP(Q66R1/T200K1). This result suggests that the
linker retains partial conformational heterogeneity. Finally, we
examined PrP(S102R1/Q222K1), with labels in the linker region
and at the C terminus of helix 3, which is just outside of the
interaction domain identified by the NMR experiments. Here,
we observe no sharpening of the distribution upon the addition
of Zn2+. Taken together, these data support the formation of
an organized structure in the presence of Zn2+ where the octar-
epeat domain docks against the surface of PrPC’s C-terminal
domain identified by the NMR experiments.
The strongly interacting PrP(Q66R1/T200K1) was further
examinedwith a Zn2+ titration experiment, as shown in Figure 4C.
The distribution derived from the DEER experiment sharpens
between 100 and 500 mMZn2+, consistent with the Zn2+ dissoci-
ation constant of 200 mM.
Pathogenic Mutants Alter the Interdomain Tertiary
Contact
We noticed that the region that forms the C-terminal docking
surface for the Zn2+ occupied octarepeats (Figure 3) also carries
the majority of the PrP point mutations that confer inherited
disease (Mead, 2006) (Figure 1). To test whether familialights reserved
Figure 3. Zn2+ Affects Specific C-Terminal
Residues
(A) Ribbon diagrams showing residues that
correspond to the disappeared (black) and signi-
ficantly shifted (dark gray) peaks in the wild-type
MoPrP.
(B and C) The corresponding surface diagram
for the full-length, wild-type MoPrP(B) and the
C-terminal construct MoPrP(91–230) (C), lacking
the Zn2+ binding N-terminal octarepeat domain.
See also Table S1 and Figure S1.
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Zinc-Driven Tertiary Interaction in PrPCmutations alter the Zn2+-driven tertiary structure, we repeated
our HSQC titration experiments with MoPrP(E199K) and
MoPrP(D177N), which correspond to the human mutations
E200K and D178N, respectively. The results, shown in Figures
5A and 5B, reveal a significant decrease, relative to wild-type,
in the number of affected C-terminal residues. Specifically,
MoPrP(E199K) shows a decrease in the size of the affected
patches on both helices 2 and 3, with 13 peaks of 99 assigned
peaks broadened to the point of being unobservable. With
MoPrP(D177N), much of the interaction with helix 2, as observed
in the wild-type protein is lost, with 17 of 94 peaks total
C-terminal peaks unobservable due to broadening.
We also examined MoPrP(P101L), corresponding to the
P102L mutation in humans that causes Gerstmann-Straussler-
Scheinker disease (Mead, 2006). This mutation, which is in the
linker between the octarepeat and C-terminal domains, results
in loss of 26 of 97 peaks due to broadening (Figure 5C). However,
whereas most of the affected residues are in helices 2 and 3,
consistent with wild-type, we also observed broadening or
disappearance of peaks from residues on the opposite side of
the C-terminal domain, suggesting interaction with the antipar-
allel b sheet.
We also investigated MoPrP(V209I), which corresponds to the
human V210I mutation that results in CJD (Prusiner, 2003). The
introduction of bulkier hydrophobic isoleucine residue to helix
3 caused 15 of 89 assigned peaks to broaden to the point of dis-
appearing. The patch of affected residues on the surface of
helices 2 and 3 in this mutant was more compact as compared
to the wild-type protein.
Finally, we performed experiments on MoPrP(Q218K), which
is the dominant negative Q219K polymorphism in humans. As
demonstrated in statistical analyses of Asian populations, indi-
viduals with this allele resist the development of sporadic CJD
(Shibuya et al., 1998). Our results show that the patches of
interaction on helices 2 and 3 are largely preserved, although
several peaks that were completely broadened in wild-type are
now visible and only partially broadened.Structure 21, 236–246, February 5, 2013The results above suggest that patho-
genic mutations lead to a systematic
weakening of the Zn2+ driven association
between PrPC’s N- and C-terminal
domains. To test this hypothesis in a
more thorough and quantitative fashion,
we determined the peak intensities of all
observable HSQC cross peaks for wild-
type and mutant proteins. Peak heightsdecrease with an increase in line width and therefore serve as
a convenient metric for residues affected by association with
the Zn2+-occupied N-terminal domain (Panchal et al., 2003).
We determined I/Io for all assigned residues in the C-terminal
helices, where I and Io are the peak intensities in the presence
and absence of Zn2+, respectively. The results are shown in
Figure 6. MoPrP(91–230), lacking the N-terminal domain,
shows only a minimal effect, as expected. Approximately half
of the residues in helices 1 and 3 are near I/Io z1. Helix 2
shows some systematic broadening near residues 178–180.
Full-length MoPrP, however, shows a dramatic decrease in I/Io
along all helical segments, with the greatest effect at helix 2. In
addition to residues broadened to zero and thus unobservable
(I/Io = 0; Figure 3), a significant number of residues are reduced
to < 0.25 of their original intensity. The greatest influence is
observed at helix 2.
Each disease-associated mutant MoPrPC gives a unique I/Io
profile. However, we observe a distinct pattern for residues
182–187 at the end of helix 2, which show a systematic increase
in I/Io relative to wild-type. To extract composite values, thus
smoothing out site-by-site variations, we determined the
average I/Io value for each helix from the set of proteins. These
values are reported to the right of each helix profile in Figure 6
and plotted in Figure 6D. Average I/Io values for helices 1 and 3
appear to be randomly distributed and show no clear pattern.
However, the average I/Io values for helix 2 cluster around two
values. Wild-type and the dominant negative Q218K show the
greatest line broadening, with average I/Io values of 0.26
and 0.23, respectively. Disease associated mutants cluster at
approximately 0.35, consistent with a systematic change of the
interaction with the Zn2+-occupied octarepeat domain.
Electrostatics Show a C-Terminal Negative Patch
at the Interaction Surface
Of the 17 pathogenic mutations in helices 2 and 3, eight involve
a shift in charge, and without exception, all of these specific
mutations increase positive charge by either loss of an acidicª2013 Elsevier Ltd All rights reserved 239
Figure 4. Zn2+-Mediated Interdomain Interaction Measured by DEER
(A) Schematic representation of MoPrP showing the location of spin-labeled side chains in relation to known secondary structures.
(B) Background-corrected dipolar evolution spectra and distance distributions obtained by Tikonov regularization for the three doubly labeled constructs in the
absence of Zn2+ (blue) and in the presence of 2mM ZnCl2 (red).
(C) Dipolar evolution spectra and distance distributions for MoPrP Q66R1/T200K1 with 0, 100, and 500 mM ZnCl2. Protein concentrations were between 80
and 100 mM.
See also Figure S2.
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Zinc-Driven Tertiary Interaction in PrPCside chain, gain of a basic side chain, or both (Shen and Ji, 2011).
Among these charge increasing mutations are those responsible
for the most prevalent inherited diseases: E200K (change of +2)
that results in the development of CJD (Mead, 2006) and D178N
(change of +1), which confers either fatal familial insomnia or
CJD, depending on the Met/Val polymorphism at position 129
(Goldfarb et al., 1992).
Based on this observation, we hypothesized that the local
increase in C-terminal positive charge presented on helices 2
and 3 would electrostatically weaken the interaction with the
Zn2+-occupied octarepeat domain. We therefore examined the
surface charge properties of these constructs using electrostatic
calculations. The NMR structure of MoPrP(121–230) (Protein
Data Bank [PDB] ID: 1XYX) was used for a surface potential
calculation and the Adaptive Poisson-Boltzmann Solver (APBS)
(Baker et al., 2001; Dolinsky et al., 2007) produced the electro-
static surface. The results show an intensely negative region240 Structure 21, 236–246, February 5, 2013 ª2013 Elsevier Ltd All rcentered between helices 2 and 3 that is composed of E199,
E206, E210, and D177 (Figure 7A). This negative patch, previ-
ously described (Zhang et al., 2000), is the same area that expe-
riences the greatest change in the 1H-15N HSQC spectra upon
the addition of zinc (Figure 3). Interestingly, other negative
regions exist on the surface of the protein, for example at the
C terminus of helix 3, but HSQC peaks corresponding to this
region are not greatly affected in the NMR experiments.
We then used computational techniques to produce structural
models of the pathogenic and dominant negative mutants, and
then examined their surface electrostatics with APBS. D177N
shows a slightly attenuated negative patch due to the loss of
charge (Figure 7B). E199K has a greater change in the negative
region owing to replacement of a negatively charged glutamate
with a positively charged lysine at the N terminus of helix 3 (Fig-
ure 7C). Q218K showed amore diffuse negative electric potential
between helices 2 and 3 (Figure 7D). These changes in theights reserved
Figure 5. C-Terminal Mutations that Affect
the Course of Prion Disease Show Different
Interaction Patterns from Wild-type
Surface diagrams showing the disappeared
(black) and significantly shifted (dark gray) peaks
in the pathogenicmutants (A–D), and the dominant
negative species (E).
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Zinc-Driven Tertiary Interaction in PrPCelectrostatics of the surface of the protein are consistent with the
peak broadening/shifting observed in the NMR spectra. We
hypothesize that the N- and C-terminal interaction may be weak-
ened in the two pathogenic mutants due to the loss of negative
charge in either helix 2 or the N terminus of helix 3.
The surface electrostatics of helices 2 and 3 are not changed in
the pathogenic mutants MoPrP(P101L) and MoPrP(V209I), and
therefore do not explain these construct’s weakened N-terminal
to C-terminal interaction. For MoPrP(P101L), the loss of the con-
formationally rigid proline residue may alter the ability of the Zn2+
occupied N terminus to wrap around and interact with the C
terminus upon zinc binding.
Given the electrostatic nature of the Zn2+-driven association
between the octarepeat and C-terminal domains, we wanted
to determine whether the interaction is enhanced by the rela-
tively low ionic strength solution in the NMR samples. All exper-
iments above were performed in 50 mMMOPS buffer (added as
a 1:1 sodium salt), which has an approximate ionic strength of
25mM. PrPC precipitates with the addition of simple monovalent
salts so, to increase ionic strength, we increased the MOPS
concentration. HSQC experiments performed at a 4-fold higher
MOPS concentration, ionic strength 100 mM, gave results
with line broadening and profiles similar to those presented in
Figures 5 and 6. Consequently, ionic strengths up to physiologic
levels do not appear to fundamentally alter the PrPC interdomain
interaction.
The concept that emerges from our findings is that the Zn2+
coordinated octarepeat domain docks to the surface of PrPC’sStructure 21, 236–246, February 5, 2013C-terminal domain formed by helices 2
and 3. This tertiary interaction is likely as-
sisted and localized by an electrostatic
attraction between the Zn2+ ion and the
negatively charged C-terminal patch
arising from a cluster of acidic residues.
To explore the feasibility and geometric
features of this higher order organization
in PrPC, we used molecular dynamics
to simulate the docking of Zn2+-bound
N terminus to the negative patch on
the C terminus of PrP. The Zn2+ ion
was coordinated by the four histidine
epsilon nitrogens within the octarepeat
domain at a set bond distance of
1.99 A˚, and defined interatom angles to
maintain tetrahedral geometry. Beyond
this, the N-terminal domain up to residue
125 was left otherwise unrestrained.
The C-terminal domain backbone was
confined to its NMR structure (PDB
1XYX). The solvated starting structurewas energy minimized and then subjected to 600 picoseconds
of simulated annealing with the two DEER-derived distance
restraints, S102 to T200 and Q66 to T200, both set at 10–20 A˚.
In addition, we included two distance restraints suggested by
the HSQC spectra and electrostatic calculations: D177 to Zn2+
and E199 to Zn2+, both at 5–15 A˚. Next, the distance restraints
were removed, and the protein was subjected to 400 picosec-
onds of constant pressure and volume simulation, which yielded
no significant changes to the protein structure. The resulting
model, Figure 8, shows that the Zn2+-bound octarepeat region
(purple) docks at the C-terminal end of helix 2 and the N-terminal
end of helix 3. The C-terminal docking surface is formed primarily
by the contiguous sequence from residue 177 to 210 (mouse
numbering), which contains the sites of the majority of mutations
in familial prion disease. The flexible Zn2+ occupied octarepeat
domain fully encompasses this surface.
DISCUSSION
Prior NMR studies on full-length PrPC found little order in the
N-terminal region preceding residue 120; treatment of PrPSc
with proteinase K cleaves away the N terminus around residue
90, but without loss of infectivity (Flechsig et al., 2000; Prusiner,
1989). As such, PrPC’s N-terminal region has often been consid-
ered an appendage—an ‘‘N-terminal tail’’—with little role in
structure or misfolding to PrPSc. Our results motivate a reconsid-
eration of this scheme. The higher order structure and tertiary
contact identified here requires a divalent metal ion cofactor toª2013 Elsevier Ltd All rights reserved 241
Figure 6. Normalized Peak Intensities Show
Different Patterns for Disease Mutants,
Relative to Wild-type and the Dominant
Negative
(A) Cross peak intensity profiles for helices 1, 2,
and 3 are compared for all proteins in this study.
Asterisks mark unassigned peaks and the dashed
lines represent the average I/Io values.
(B) A plot of the average I/Io for each helix
comparing wild-type and protective mutant (black
squares) with pathogenic mutants (gray circles).
Residues in helix 2 exhibit lower I/Io (greater
broadening) for wild-type and dominant negative
compared to familial mutants.
See also Table S1 and Figure S1.
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Zinc-Driven Tertiary Interaction in PrPCcoordinate to the four conserved, octarepeat His residues. Both
NMR and EPR show consistently that the Zn2+-occupied
octarepeat domain makes a tertiary contact encompassing the
surface on the C-terminal domain formed by helices 2 and 3.
HSQC experiments with full-length wild-type protein in the
presence of Zn2+ show the greatest influence on the C-terminal
residues, as indicated by peak broadening. In contrast, parallel
NMR experiments with PrP(91–230) lacking the octarepeat
domain show almost no change in C-terminal line shapes or
chemical shift. PrPC mutants are intermediate between these
two extremes. It is logical, therefore, to propose that the
N-terminal to C-terminal interaction is weakened relative to
wild-type in the familial mutant proteins. However, because the
spectra for all full-length proteins are in intermediate exchange,
we treat this interpretation with caution. The mutations may
influence the dynamics of the loops between the N-terminal
histidines that coordinate Zn2+, chemical exchange between
N-terminal and C-terminal open and closed structures, or the
chemical shifts at the interface. Nevertheless, the clustering of242 Structure 21, 236–246, February 5, 2013 ª2013 Elsevier Ltd All rights reservedthe average line width of the helix 2
resides among wild-type and the Q218K
versus that observed for the familial
mutants (Figure 6D) strongly suggests
that the latter proteins possess systemat-
ically altered structures or dynamics.
Our results reveal a previously unseen
correlation between inherited prion
disease mutations and an in vitro struc-
tural change in PrP. Early investigations
hypothesized that mutations would ther-
modynamically destabilize the C-terminal
structure of PrPC, rendering the protein
susceptible to misfolding (Cohen et al.,
1994; Huang et al., 1994). However,
structure and denaturation studies reveal
only minimal changes in three-dimen-
sional fold, and no systematic variation
in stability (Bae et al., 2009; Biljan et al.,
2011; Ilc et al., 2010; Lee et al., 2010;
Liemann and Glockshuber, 1999; Swiet-
nicki et al., 1998; Zhang et al., 2000).
Our investigation of the pathogenic
mutants shows that the D177N andE199K mutations systematically alter the N-terminal to
C-terminal tertiary interaction, likely by reducing the negative
surface potential on helices 2 and 3 that attracts the Zn2+-bound
N terminus. Thus, this class of charge-altering mutations may
reduce stability by affecting the new tertiary fold in PrPC revealed
here. It has been noted that familial disease arises frommutation
directional selection in which all mutations either increase posi-
tive charge or hydrophobicity (Shen and Ji, 2011). Our findings
provide a preliminary explanation for those mutations involving
a change in charge. In contrast, in the cases of P101L and
V209I, surface electrostatics cannot explain the reduced interac-
tions we observed at helix 2. The loss of proline may remove
conformational restrictions in the linker region, resulting in inhibi-
tion of the interdomain interaction. Data in Figure 5 do suggest
that the Zn2+-occupied octarepeats in MoPrPC(P101L) make
contact with the C-terminal domain on the surface opposite to
that formed by helices 2 and 3, possibly due to alteration in linker
conformation. In contrast to findings with the familial disease
mutations, the dominant negative mutant Q218K, located near
Figure 7. Electrostatic Surface Diagrams of
Wild-type MoPrP and Mutants
(A) Wild-type as compared to the pathogenic
mutants in (B) and (C).
(D) The dominant negative. Blue denotes positive
charge and red is negative charge.
Figure 8. Model of the Zn2+-Mediated N-Terminal to C-Terminal
Interaction
The octarepeat domain (purple) containing the bound Zn2+ (red) was docked
against the relevant C-terminal surface using restraints from DEER and NMR.
The acidic residues that define the negative patch on helices 2 and 3 are
highlighted.
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Zinc-Driven Tertiary Interaction in PrPCthe end of helix 3, results in a modest strengthening of the Zn2+-
driven tertiary interaction when compared to the wild-type and
pathogenic mutants. From this perspective, a weakening of the
N- and C-terminal interaction may contribute to disease while
a strengthening of the interaction may be protective.
This zinc-mediated N-terminal to C-terminal interaction may
contribute to the understanding of PrP’s function and trafficking
in the cell. Zn2+ initiates PrPC internalization through endocytosis
(Pauly and Harris, 1998; Perera and Hooper, 2001). Coordination
to PrPC is hypothesized to cause a conformational transition
that moves the protein laterally out of lipid rafts to be endocy-
tosed via clathrin-coated pits (Hooper et al., 2008). The structural
change induced by zinc binding identified here offers an expla-
nation. The Zn2+-driven tertiary association could either displace
a lipid raft targeting protein, or create a binding site for proteins
that facilitate PrP’s endocytosis, such as LRP1 (low-density
lipoprotein receptor-related protein 1). Similarly, PrP is hypothe-
sized to act as a zinc sensor, in which it detects extracellular
levels up to a threshold (Watt and Hooper, 2003). Exceeding
this threshold initiates a signal transduction cascade that
enables the cell to protect itself against toxic amounts of metal.
The conformational change caused by the interdomain interac-
tion may act as the trigger for this signal cascade. To this junc-
ture, we’ve considered the N-terminal to C-terminal interaction
as an intramolecular property. However, given the length of the
linker region between the PrPC domains, it is also possible that
proximal PrPC copies domain-swap, with the N-terminal domain
of one PrPC docking to the C-terminal domain of its neighbor. In
this scenario, Zn2+ facilitates noncovalent crosslinking that could
stimulate transmembrane processes.
It is well established that PrPC takes up both Cu2+ and Zn2+
(Chattopadhyay et al., 2005; Jackson et al., 2001; Millhauser,
2007; Walter et al., 2007). Our initial experiments here focused
on zinc because it binds with only one coordination mode and
is diamagnetic, thus avoiding paramagnetic line broadening.
However, a recently published NMR study with PrPC in the pres-
ence of excess copper showed an interaction at helix 2, residues
174–185 (Thakur et al., 2011), which is supported by our resultsStructure 21, 236–246, February 5, 2013here. At full Cu2+ saturation, however,
the N-terminal domain can take up to
six equivalents, so developing a three-
dimensional structure based on para-
magnetic line broadening is challenging.
Nevertheless, it is clearly important to
evaluate how metal-driven tertiary struc-
ture varies with concentration, and for
example, whether low versus high Cu2+
levels drive additional conformational
transitions.
In summary, our findings here reveal
a tertiary structure in PrPC, assisted byZn2+ coordination in the octarepeat domain. The correlation we
find with familial disease mutants suggests that stabilization of
this tertiary fold creates a barrier to misfolding and the formation
of PrPSc. In support of this, both Cu2+ and Zn2+ inhibit in vitro
amplification of prions (Orem et al., 2006). Small molecules orª2013 Elsevier Ltd All rights reserved 243
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Zinc-Driven Tertiary Interaction in PrPCaccessory proteins that support this fold could serve in the treat-
ment of the TSEs.
EXPERIMENTAL PROCEDURES
15N-Labeled Protein Expression
MoPrP variants (created with the GeneArt Site Directed Mutagenesis kit
[Invitrogen]) were constructed using the template plasmid pET101 MoPrP
(Invitrogen) containing full-length Mus musculus PrP(23–230). The C-terminal
fragment, MoPrP(91–230), was cloned into the pET101 vector using EcoRI and
XhoI restriction sites. All constructs and mutations were confirmed by DNA
sequencing. Protein expression was executed in Escherichia coli BL21Star
(DE3) (Invitrogen). All 15N-labeled proteins were grown in M9 minimal media
supplemented with 1 g L1 15N ammonium chloride. Cells were grown at
37C until they reached an OD600 of 0.6, at which they were then transferred
to the M9 minimal media and protein expression was induced with 1 mM
isopropyl-1-thio-D-galactopyranoside (IPTG) for 3 hours. The full-length
constructs were solubilized from inclusion bodies in 8 M urea and run over
a Ni2+ charged immobilized metal affinity column (IMAC) on an AKTA purifier
system (GE Healthcare). MoPrP(91–230) was purified from inclusion bodies
prior to running over aQ-Sepharose anion exchange column. All of the proteins
were then further purified using reverse phase high-performance liquid chro-
matography (HPLC), and subsequently identified by mass spectrometry. The
proteins were then lyophilized and quantified in guanidinium chloride (GdHCl)
by UV-vis spectrophotometry prior to use in the NMR experiments.
Spin-Labeled PrP Sample Preparation
Expression of mutant PrP for dual spin-labeling was achieved by a method
similar to one described previously (Fleissner et al., 2009). Briefly, PrP contain-
ing site-specific cysteine and amber (TAG) codon mutations were cotrans-
formed into BL21(DE3) cells along with the pEVOL vector specific for pAcPhe
incorporation (Young et al., 2010). The growth media was supplemented with
400 mg/L pAcPhe (Synchem) and the cells were grown to an OD600 of 0.6 to
0.8. Expression was induced with 1 mM IPTG and 300 mg/l L-Arabinose and
the cells were incubated for an additional 5–7 hr at 37C.
Ni2+ affinity purification and HPLC were performed as described above.
HPLC purified protein was then buffer-exchanged into 10 mM sodium acetate
pH 4.5 and concentrated through a 10-kDa MWCO membrane (Amicon). A
10-fold molar excess of MTSSL spin label (Toronto Research Chemicals)
was added and allowed to react for 6–12 hr at room temperature. The reaction
mixture was again purified by HPLC and lyophilized. The dried protein was dis-
solved in 10 mM sodium acetate buffer at pH 4 to a concentration of approx-
imately 100 mM. A 10-fold molar excess of the hydroxylamine spin label
HO-4120, synthesized in-house using published procedures (Fleissner et al.,
2009; Hankovszky et al., 1981; Powell et al., 2000), was added and the reaction
was incubated at 37C for 24–28 hr before a final round of HPLC purification.
Samples for EPR were made in 25mMMOPS pH 7.4 in D2O containing 30%
v/v d8-glycerol. Samples containing Zn2+ were made using a stock solution of
ZnCl2 in D2O. Double spin-labeled samples were loaded into 4 mm (o.d.)
quartz EPR tubes (Wilmad 707-SQ) and flash frozen in liquid nitrogen prior
to spectral analysis.
Nuclear Magnetic Resonance Spectroscopy
All samples were prepared in a buffer containing 50mM MOPS hemisodium
salt (Sigma), 10% D2O, 0.1% NaN3, and 0.2 mM TMSP at pH 7.39, except in
the case of varying salt concentrations where 25 mM and 200 mM MOPS
was used. Protein was added to final concentration of 50 mM and either
50 mM or 150 mM ZnCl2 was added to the samples containing zinc. Zn
2+
concentrations beyond this tended to result in protein precipitation. 1H-15N
HSQC spectra were recorded at 25C on an Avance II 900-MHz spectrometer
(Bruker-Biospin, Boston, MA) at the Central California 900-MHz NMR facility
(Berkeley, CA). NMR spectra were analyzed with NMR Pipe and Sparky.
Structural analysis was done with UCSF Chimera.
Double Electron-Electron Resonance Spectroscopy
4-pulse DEER data was collected on a Bruker ELEXSYS E580 X-band spec-
trometer equipped with an MD-5 dielectric resonator and a second frequency244 Structure 21, 236–246, February 5, 2013 ª2013 Elsevier Ltd All rDEER module (Bruker). The pump pulse was fixed to the center peak in the
field swept nitroxide spectrum and the probe frequency was chosen
65–75MHz above this frequency.p/2 andp pulses were 16 and 32 ns, respec-
tively. The delay between the first and second probe pulses was 400 ns and
dipolar evolution data was collected out to 2.5–3.5 ms. Experiments were run
at 50 or 80 K, depending on the sample, and were signal averaged for
6–8 hr. The raw data was background corrected and analyzed by Tikhonov
regularization using the DeerAnalysis 2011 software package (Jeschke
et al., 2006).
Electrostatic Calculations
The electrostatic calculations were performed on MoPrP(121–230) (PDB ID:
1XYX) with the Adaptive Poisson-Boltzmann Solver (APBS) plug-in in PyMol
(Baker et al., 2001). The mutations in the pathogenic mutants were introduced
with the swapaa command in Chimera (starting PDB ID: 1XYX), prior to calcu-
lating the surface electrostatics with APBS.
Molecular Dynamics Simulations
The molecular dynamics simulation package GROMACS (Berendsen et al.,
1995; Lindahl et al., 2001) was used to create a molecular model of the inter-
domain interaction using the OPLS-AA/L force field (Jorgensen et al., 1996;
Kaminski et al., 1994) and SPC water model (Berendsen et al., 1981, 1984).
Dr. M. Jake Pushie generously donated the starting structure with Zn2+ bound.
The initial structure was subjected to 1000 steps of steepest-descent energy
minimization in the presence of explicit solvent. The protein was then sub-
jected to 600 picoseconds of simulated annealing with four additional distance
restraints derived from the magnetic resonance experiments. After the protein
structure stabilized, 400 picoseconds of production molecular dynamics
simulation was run to produce the final model.
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